Influence of a randomized monoclonal or polyclonal program of therapy on cytomegalovirus infection in kidney transplantation

Transplant Proc. 1991 Feb;23(1 Pt 2):1361-2.

Authors

P Raffaele¹, C Pouteil-Noble, N Lefrancois, S Bosshard, H Betuel, M Aymard, J M Dubernard, J L Touraine

Affiliation

¹ Transplantation Unit, E. Herriot Hospital, Lyon, France.

PMID: 1846465

No abstract available

Publication types

Clinical Trial
Randomized Controlled Trial

MeSH terms

Antibodies, Monoclonal / administration & dosage*
Antilymphocyte Serum / administration & dosage*
Cytomegalovirus Infections / complications*
Graft Rejection
HLA Antigens / immunology
Histocompatibility
Humans
Immunosuppression Therapy / methods
Kidney Transplantation / methods*
Muromonab-CD3

Substances

Antibodies, Monoclonal
Antilymphocyte Serum
HLA Antigens
Muromonab-CD3